Gentiopicroside Alleviates Type 2 Diabetes Mellitus by Ameliorating Hepatic Oxidative Stress via Activation of the PI3K / AKT /Nrf2 Signaling Pathway
The FASEB Journal · 30.04.2026 · 40 (8)
DOI: 10.1096/fj.202600873r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 22.04.2026. Verfasst von Xing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Iridoid Glucosides, Oxidative Stress, NF-E2-Related Factor 2, Diabetes Mellitus, Type 2. Die Arbeit nennt 54 Literaturangaben. Gefördert von: the Joint Fund Project of Science and Technology Education in Sichuan Province, the Project of Sichuan Provinical Administration of Traditional Chinese Medicine, Nanchong Science and Technology Plan Project.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gentiopicroside (GPS), derived from Gentiana manshurica, exhibits multiple pharmacological activities, such as anti‐inflammatory and antioxidant effects, but its role and mechanisms in treating type 2 diabetes mellitus (T2DM) remain unclear. This study explored GPS's therapeutic effects and underlying mechanisms in vitro and in vivo. In a T2DM mouse model induced by a high‐fat diet (HFD) and streptozotocin (STZ), the results demonstrated that GPS significantly relieved diabetic symptoms, corrected oral glucose tolerance impairment, enhanced insulin sensitivity, and ameliorated lipid metabolism disorders. GPS also increased the activities of antioxidant enzymes, elevated the levels of antioxidant substances, reduced malondialdehyde (MDA) in serum and liver, and ameliorated hepatic insulin resistance (IR). In palmitic acid (PA)‐induced HepG2 cells, GPS dramatically inhibited PA‐induced cytotoxicity and oxidative stress by increasing glutathione (GSH) levels and superoxide dismutase (SOD) activities while lowering malondialdehyde (MDA) levels, and reversed PA‐induced IR. Mechanistically, GPS regulated protein expression in the PI3K/AKT/Nrf2 pathway and promoted Nrf2 nuclear translocation in both models. More importantly, further studies revealed that LY294002 (a PI3K inhibitor) or ML385 (an Nrf2 inhibitor) suppressed the protective effects of GPS against PA‐induced hepatic oxidative damage. In conclusion, GPS alleviates hepatic oxidative damage, IR and delays the progression of T2DM through activating the PI3K/AKT/Nrf2 signaling pathway, providing an important foundation for further development and utilization of GPS. However, this study still has limitations including the lack of a positive control drug and insufficient exploration of the relevant molecular mechanisms, and will further improve the research and explore the clinical potential of GPS in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
- Nanchong Key Laboratory of Disease Prevention, Control and Detection in Livestock and Poultry, Nanchong Vocational and Technical College, Nanchong, China.
- Department of Pharmacy, Minhang Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Xing Wang
Förderung
- the Joint Fund Project of Science and Technology Education in Sichuan Province
- the Project of Sichuan Provinical Administration of Traditional Chinese Medicine
- Nanchong Science and Technology Plan Project
- The Innovation and Entrepreneurship Training Program for College Students in Sichuan Province
- The Scientific Cultivation Project of Outstanding Young People in North Sichuan Medical College
- The Scientific Research Development Plan Project of the Affiliated Hospital of Clinical Medical College of North Sichuan Medical College
- The Medical Specialty Project of Minhang District
- The Natural Science Research Project of Shanghai Minhang District
Zitieren
APA
Wang, X., Long, D., Wu, L., Xie, Q., Peng, X., Luo, S., Li, H., Zhou, M., & Guo, N. (2026). Gentiopicroside Alleviates Type 2 Diabetes Mellitus by Ameliorating Hepatic Oxidative Stress via Activation of the PI3K / AKT /Nrf2 Signaling Pathway. The FASEB Journal, 40(8). https://doi.org/10.1096/fj.202600873r
Vancouver
Wang X, Long D, Wu L, Xie Q, Peng X, Luo S, et al. Gentiopicroside Alleviates Type 2 Diabetes Mellitus by Ameliorating Hepatic Oxidative Stress via Activation of the PI3K / AKT /Nrf2 Signaling Pathway. The FASEB Journal. 2026;40(8). doi:10.1096/fj.202600873r
BibTeX
@article{Wang2026,
author = {Wang, Xing and Long, Dongmei and Wu, Linlin and Xie, Qitong and Peng, Xingcan and Luo, Siyao and Li, Huijuan and Zhou, Maoting and Guo, Nan},
title = {Gentiopicroside Alleviates Type 2 Diabetes Mellitus by Ameliorating Hepatic Oxidative Stress via Activation of the PI3K / AKT /Nrf2 Signaling Pathway},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {8},
doi = {10.1096/fj.202600873r}
}
EUVIMED